Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-31

Study Completion Date

2034-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

T2DM has become a major health burden for our society. More and more data support the relative effectiveness of gastrointestinal metabolic surgery, known as bariatric surgery, in the remission of T2DM of BMI less35. The metabolic surgery guidelines of IDF recommend BMI over 27.5 in Asia.

The evidence reviewed above strongly points to the need for a large randomized, controlled trial to evaluate the risks and benefits of obesity surgery in the treatment of type 2 diabetes Mellitus. This study is expected to provide very significant findings about the natural course of diabetes in obese diabetic patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Asian Diabetes Surgery Study (ADSS): Clinical Predictor for the Success of Metabolic Surgery

NCT01317979

Disease Endocrine System Disease Diabetes Mellitus

UNKNOWN

A Prospective Study on Diabetes Management Through an Integrated Delivery System

NCT00288678

Diabetes Mellitus

COMPLETED PHASE3

Study to Evaluate the Effect of the Smart Care-diabetes Management System on Subjects With Diabetes

NCT01505036

Diabetes Mellitus

COMPLETED NA

Metabolic Syndrome and Prediabetes

NCT07243821

Metabolic Syndrome Diabetes

RECRUITING

Tzu Chi Health Study (Diabetes and Cardiometabolic Health Components)

NCT03204552

Diabetes Fatty Liver Cardiometabolic Health +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will recruit 200 obese T2DM patients at MSGH, for a total of 1000 in Taiwan. The inclusion criteria are those with T2DM more than 6 months, under medical management in diabetes center, BMI over 25, age between 20 and 67 years. The goals of this study are to evaluate the nature course of the diabetes for 10 years. The primary outcomes for the treatment will be assessed every year after intervention and will be composite of CVD risk factor; specifically, the proportion of patients with HbA1c \< 7%, LDL cholesterol \< 100 mg/dl and systolic blood pressure \< 140 mmHg.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obese diabetic patients

Diabetic patients with BMI over 25 Age 20 to 67 Diabetes medically controlled at our center for at least six months

Observation of natural course of Diabetes Mellitus Type 2

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observation of natural course of Diabetes Mellitus Type 2

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diabetic Mellitus Type 2 medically controlled at Diabetes Center for at least six months
* BMI over 25
* age between 20 and 67

Exclusion Criteria

* Diagnosed with cancer within past five years
* HIV positive
* Active TB patients
* CV events in past six months
* serum cretinine over 2.0 mg/dl
* C-peptide bellow 1.0 ng/ml in past three months
* Diabetic retinopathy; vision bellow 0.1
* Cushing's syndrome
* History of organ transplant
* History of bariatric surgery
* History of alcohol or drug dependency in past five years
* Psychological problems likely to interfere with adherence to protocol

Minimum Eligible Age

20 Years

Maximum Eligible Age

67 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes